Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
FDA Approvals
FDA Approvals
Plethora of Targeted Agents in the Oncology Pipeline
David Knight
Read More
Payers' Guide
,
FDA Approvals
Tecentriq (Atezolizumab) First PD-L1 Inhibitor Approved for Patients with Advanced or Metastatic Urothelial Carcinoma
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety
Phoebe Starr
Read More
FDA Approvals
Novel Vaccine Induces Immunologic Responses in Patients with Acute Myeloid Leukemia
Wayne Kuznar
Read More
FDA Approvals
New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence
Phoebe Starr
Read More
FDA Approvals
Novel Chimeric Monoclonal Antibody Improves Survival in Advanced Gastric Cancers
Wayne Kuznar
Read More
FDA Approvals
Adding the BCL-2 Inhibitor Venetoclax to Treatment Regimen Promising in Relapsed or Refractory Multiple Myeloma
Wayne Kuznar
Read More
In the News
,
FDA Approvals
“Smart Bomb” First-in-Class Drug Rova-T Promising Novel Therapy for Small-Cell Lung Cancer
Phoebe Starr
Read More
FDA Approvals
The Oncology Drug Pipeline Shows No Evidence of Slowing Down
Wayne Kuznar
Read More
FDA Approvals
,
In the News
Nuplazid First Drug Approved for Hallucinations and Delusions Associated with Parkinson’s Disease
Read More
31
32
33
34
35
36
37
Page 34 of 53
Results 331 - 340 of 525
